» Articles » PMID: 12233958

Fatal Methadone Toxicity: Signs and Circumstances, and the Role of Benzodiazepines

Overview
Publisher Elsevier
Specialty Public Health
Date 2002 Sep 18
PMID 12233958
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the signs and symptoms and circumstances of fatal methadone toxicity and investigate the role of benzodiazepines in these deaths.

Methods: Data were extracted from 1994 New South Wales (NSW) coronial files and cause of death established independently. Cases were grouped according to the likely source of methadone. Data describing the clinical history and circumstances of death were extracted from witnesses' and police statements.

Results: Methadone contributed to the deaths of 57 of the 87 adult coronial cases in which it was detected in NSW in 1994. The most commonly reported early signs of severe methadone toxicity were ataxia, slurred speech and evident euphoria. The late signs were unconsciousness, loud snoring and brown pulmonary oedema fluid coming from the mouth or nose. Death occurred an average 5.1 and 6.0 hours after oral ingestion and intravenous injection of methadone, respectively. Benzodiazepines were significantly more likely to have contributed to deaths from methadone toxicity among maintenance patients and people taking methadone tablets for pain relief than deaths involving diverted methadone syrup and deaths to which methadone did not contribute (OR 4.8, 95% 1.7 to 14.4).

Conclusions And Implications: Benzodiazepines may contribute to deaths from methadone toxicity by increasing upper airways obstruction. Victims would have had a greater chance of survival if they had either been placed in the coma position or given mouth-to-mouth ventilation and an ambulance had been called. Benzodiazepines are more likely to contribute to fatal methadone toxicity in newly admitted maintenance patients and those taking methadone tablets for pain relief.

Citing Articles

Drug overdose deaths during prison riots and mental states of prisoners: a case study.

Tomassini L, Giuli G, Bottoni E, David M, Scendoni R Front Psychiatry. 2024; 15:1377995.

PMID: 39345919 PMC: 11427281. DOI: 10.3389/fpsyt.2024.1377995.


The Role of Risk or Contributory Death Factors in Methadone-Related Fatalities: A Review and Pooled Analysis.

Giorgetti A, Pascali J, Montisci M, Amico I, Bonvicini B, Fais P Metabolites. 2021; 11(3).

PMID: 33810163 PMC: 8004630. DOI: 10.3390/metabo11030189.


Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK.

Abouchedid R, Gilks T, Dargan P, Archer J, Wood D J Med Toxicol. 2018; 14(2):134-143.

PMID: 29671244 PMC: 5962469. DOI: 10.1007/s13181-018-0659-3.


Prevalence of pulmonary edema among the deceased cases with acute Methadone poisoning: A report from Iran.

Eizadi-Mood N, Naeini S, Hedaiaty M, Sabzghabaee A, Moudi M J Res Pharm Pract. 2016; 5(4):290-293.

PMID: 27843967 PMC: 5084488. DOI: 10.4103/2279-042X.192454.


Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs.

Bach P, Walton G, Hayashi K, Milloy M, Dong H, Kerr T Am J Public Health. 2016; 106(6):1067-72.

PMID: 26985601 PMC: 4880240. DOI: 10.2105/AJPH.2016.303090.